Stocks · News reference
UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $73
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $67 to $73.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
GE HealthCare Unveils Next-Gen Vivid Cardiovascular Ultrasound Portfolio, With Vivid Explorer, Vivid Advanced And Vivid Focus, For Advanced Imaging Across Cardiology Care Settings
Vivid™ Explorer, Vivid™ Advanced and Vivid™ Focus systems bring cSound™ imaging with capabilities designed for routine echocardiography, comprehensive cardiac imaging and interventional careGE HealthCare (NASDAQ:GEHC)
FDA Announces GE Healthcare Issues Early Alert For Portrait Core Services Software Issue
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-portrait-core-services-software-issue-ge-healthcare
BTIG Reiterates Buy on GE HealthCare Techs, Maintains $79 Price Target
BTIG analyst Ryan Zimmerman reiterates GE HealthCare Techs (NASDAQ:GEHC) with a Buy and maintains $79 price target.